FDA Panel Casts SSRIs During Pregnancy as Risky—Many Experts Disagree | Synapse
September 10, 2025
FDA Panel Casts SSRIs During Pregnancy as Risky—Many Experts Disagree
Key Points
SSRIs are deemed risky during pregnancy, according to an FDA panel, yet many specialists argue against this view.
The panel's conclusions may influence treatment options for pregnant individuals, contributing to an ongoing debate.
Expert disagreement on antidepressant safety in pregnancy raises questions about patient care and medication guidelines.
The FDA's stance on SSRIs could lead to more scrutiny on prescribing practices and further investigations.
Abstract
This Medical News article discusses claims about antidepressant treatment during pregnancy presented at a recent panel organized by the US Food and Drug Administration.